$AVGONeutralMed

Weekend Round-Up: Anthropic Eyes IPO, CrowdStrike's Stock Split, Broadcom's Mixed Results, SpaceX's AI De

Anthropic filed a confidential draft Form S-1 with the SEC, giving it the option to pursue an IPO, though share count and pricing weren’t set. CrowdStrike reported Q1 revenue of $1.39B vs $1.36B estimates and announced a 4-for-1 stock split. Broadcom’s Q2 revenue was $22.19B vs $22.27B estimates, with adjusted EPS of $2.44 vs $2.40. SpaceX signed a $920M monthly AI deal with Google.

6/10
4/10
Med
Neutral
weekend recap; catalysts likely to be digested at next market open
generally aligns with AI/tech risk-on for CROX/AVGO/META split, with contract-driven optimism for GOOGL/GOOG/NVDA

Mixed top-line vs EPS beat, offset by strong AI semiconductor growth, may keep the stock range-bound unless investors focus on margin/AI demand trajectory.

Broadcom posted Q2 revenue of $22.19B (slightly below estimates) but adjusted EPS of $2.44 (above estimates), with 48% YoY AI semiconductor growth.

Choppy/neutral-to-slightly positive reaction risk; focus likely shifts to AI segment sustainability and any implied margins.

Background

The piece is a weekend roundup covering: Anthropic’s confidential SEC filing for a potential IPO, CrowdStrike’s Q1 beat plus 4-for-1 split, Broadcom’s mixed Q2 results with AI semiconductor growth, a SpaceX AI contract with Google, Meta investor concerns tied to AI capex, and a reported US government-stake discussion with major AI firms.

Why it matters

Traders should focus on the concrete catalysts: CrowdStrike’s split and Q1 figures, Broadcom’s revenue/EPS mix with AI growth, Meta’s capex-driven earnings skepticism, and the specificity of the SpaceX-Google GPU deal (demand read-through to Nvidia).

Market relevance

This roundup contains multiple discrete, tradable catalysts (earnings prints, split, and a large AI contract) plus sentiment pressure around Meta’s AI spending.

Market effects

AI capex and GPU demand narratives get reinforced (SpaceX/Google deal) while cybersecurity and semis remain driven by earnings quality vs revenue growth.

Primarily US-listed tech/semis sentiment; limited direct regional linkage beyond broad risk appetite.

GPU-heavy AI infrastructure deal underscores ongoing global AI buildout and supply-chain demand.

Alternative perspectives

Investor skepticism around Meta’s massive AI capex could dominate if earnings trajectory doesn’t improve, offsetting any long-term AI upside narrative.

For CROX/AVGO, the article lacks explicit forward guidance; market reaction may hinge more on margins, backlog/ARR quality, and segment commentary than on the headline beat/miss.

Key entities

  • CrowdStrike

    Reported Q1 revenue beat and announced a 4-for-1 stock split.

  • Broadcom

    Reported Q2 revenue slightly below estimates but adjusted EPS beat; AI semiconductor revenue grew 48% YoY.

  • Meta

    Investor selloff linked to reports of $145B AI-related capex this year.

  • Google

    SpaceX signed a $920M monthly AI deal with Google using 110,000 Nvidia GPUs.

  • SpaceX

    Signed the AI deal with Google; ramp schedule to full rate by Sept 2026.

Related articles

$NVDALow

Nvidia and SK hynix to Partner as Jensen Huang Warns Memory Shortage Could ‘Last for Years’

Nvidia CEO Jensen Huang met SK hynix leadership in Seoul and, according to CNBC, said the global memory shortage could persist for several years. The report says Nvidia and SK hynix are deepening cooperation around high-bandwidth memory used in Nvidia’s Blackwell platforms, with SK hynix supplying an estimated 50%–70% of Nvidia’s HBM4 needs. Investors may view this as multi-year supply planning amid constrained capacity.

$METALow

Why U.S. Privacy Laws Werent Built for AI Smart Glasses

The article says AI-equipped smart glasses have enabled covert recording and real-time identification, raising privacy concerns. It cites a 2024 Harvard project (I‑XRAY) that could identify people using Meta’s Ray‑Ban AI glasses and facial recognition, and notes Meta has sold over 8 million pairs since 2024. It also reports leaked plans to add facial recognition, regulatory gaps, and a March 2026 class action lawsuit.

$AVGOMedAI 8/10

Down 20%, Should You Buy Broadcom Stock on the Dip? The Answer Might Surprise You.

Broadcom’s shares fell about 20% after its fiscal 2026 Q2 results, as the company’s forward guidance for AI semiconductor revenue missed Wall Street expectations, according to the article. Broadcom reported $22.2B total revenue (+48% YoY) and $10.8B AI revenue (+143% YoY), with Q3 AI guidance of $16B (+200% YoY). The stock still trades at a high P/S (24.9) and P/E (64.1).

$METAMed

Meta Wants AI Agents to Become Its Next Ad Business

Meta is rolling out “AI agents” for businesses across WhatsApp, Instagram, and Messenger, according to a Wall Street Journal report. The agents are designed to handle tasks such as answering customer questions, booking appointments, managing calendars, and conducting market research. The company is also pursuing higher capex, with guidance of $125–$145 billion, as it seeks to diversify revenue beyond ads.